Bariatric surgery among patients with heart failure: a systematic review and meta-analysis

被引:32
作者
Berger, Sebastian [1 ,2 ]
Meyre, Pascal [1 ,2 ]
Blum, Steffen [1 ,2 ]
Aeschbacher, Stefanie [1 ,2 ]
Ruegg, Marco [2 ]
Briel, Matthias [3 ,4 ]
Conen, David [1 ,2 ,5 ]
机构
[1] Univ Hosp Basel, Dept Med, Cardiol Div, Basel, Switzerland
[2] Univ Hosp Basel, Cardiovasc Res Inst Basel, Basel, Switzerland
[3] Univ Basel, Univ Hosp Basel, Dept Clin Res, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland
[4] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[5] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
关键词
D O I
10.1136/openhrt-2018-000910
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Bariatric surgery reduces cardiovascular risk in obese patients. Heart failure (HF) is associated with an increased perioperative risk following bariatric surgery. This systematic review aimed to assemble the evidence on bariatric surgery in patients with known HF and the potential effect of bariatric surgery on incident HF in obese patients without prevalent HF. Methods We performed a comprehensive literature search up to 30 September 2017 and included studies comparing bariatric surgery to non-surgical treatment in patients with known presurgical HF. To assess whether bariatric surgery has any effect on incident HF, we also assembled studies looking at new-onset HF among patients without HF prior to surgery. Results We found five observational studies (0 randomised trials) comparing bariatric surgery with non-surgical treatment in patients with a diagnosis of HF prior to surgery. A review of the available studies (n=676 patients) suggested reduced admission rates for HF exacerbation and increased left ventricular ejection fraction after bariatric surgery. No meta-analysis was possible due to the heterogeneous nature of these studies. Seven studies (one randomised trial) reported data on new-onset HF in obese patients without HF prior to bariatric surgery (n=111 127 patients). When comparing surgical to non-surgical treatment groups, the pooled univariable and multivariable HRs for incident HF were 0.28 (95% CI 0.13 to 0.55) and 0.44 (95% CI 0.36 to 055), respectively. Conclusion In this systematic review, no randomised trial assessed the benefits and risks of bariatric surgery in obese patients with concomitant HF. Available studies do, however, show that surgery might prevent incident HF.
引用
收藏
页数:9
相关论文
共 42 条
[1]  
McMurray J.J., Petrie M.C., Murdoch D.R., Et al., Clinical epidemiology of heart failure: Public and private health burden, Eur Heart J, 19, pp. P9-16, (1998)
[2]  
Ng M., Fleming T., Robinson M., Et al., Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013, Lancet, 384, pp. 766-781, (2014)
[3]  
Flegal K.M., Kruszon-Moran D., Carroll M.D., Et al., Trends in obesity among adults in the United States, 2005 to 2014, JAMA, 315, pp. 2284-2291, (2016)
[4]  
Body Mass Index by Sex, Age and Educational Attainment Level 2017, (2017)
[5]  
Kenchaiah S., Evans J.C., Levy D., Et al., Obesity and the risk of heart failure, N Engl J Med, 347, pp. 305-313, (2002)
[6]  
Kenchaiah S., Sesso H.D., Gaziano J.M., Body mass index and vigorous physical activity and the risk of heart failure among men, Circulation, 119, pp. 44-52, (2009)
[7]  
Aune D., Sen A., Norat T., Et al., Body mass index, abdominal fatness, and heart failure incidence and mortality: A systematic review and dose-response meta-analysis of prospective studies, Circulation, 133, pp. 639-649, (2016)
[8]  
Brouwers F.P., De Boer R.A., Van Der-Harst P., Et al., Incidence and epidemiology of new onset heart failure with preserved vs. Reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND, Eur Heart J, 34, pp. 1424-1431, (2013)
[9]  
Ho J.E., Lyass A., Lee D.S., Et al., Predictors of new-onset heart failure: Differences in preserved versus reduced ejection fraction, Circ Heart Fail, 6, pp. 279-286, (2013)
[10]  
McMurray J., Ostergren J., Pfeffer M., Et al., Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: Baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme, Eur J Heart Fail, 5, pp. 261-270, (2003)